Lapinitab
Brand Name: Lapinitab
Generic Name: Lapatinib (as ditosylate monohydrate)
Active
Registration Number
DRP-13558-02
Dosage Form
Film-Coated Tablet
Issuance Date
March 1, 2024
Expiry Date
March 9, 2028
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength250 mg
PackagingHDPE Bottle x 30 tablets / (Box of 1 bottle x 30 tablets)
Classification
C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Antineoplastic Agent
A
Application
CLIDP Conversion
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
Lapatinib (as ditosylate monohydrate)Active
Monograph: lapatinib (as ditosylate monohydrate)